Allstate Corporation’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.7M | Buy |
182,470
+47,985
| +36% | +$10.6M | 0.42% | 34 |
|
|
2025
Q4 | $30.7M | Buy |
134,485
+70,284
| +109% | +$16M | 0.42% | 31 |
|
|
2025
Q3 | $14.9M | Buy |
64,201
+60,654
| +1,710% | +$12.4M | 0.34% | 38 |
|
|
2025
Q2 | $658K | Sell |
3,547
-57,513
| -94% | -$10.7M | 0.05% | 58 |
|
|
2025
Q1 | $12.8M | Buy |
61,060
+8,561
| +16% | +$1.66M | 0.38% | 36 |
|
|
2024
Q4 | $9.33M | Buy |
52,499
+50,866
| +3,115% | +$9.35M | 0.27% | 38 |
|
|
2024
Q3 | $322K | Sell |
1,633
-4,223
| -72% | -$788K | 0.03% | 86 |
|
|
2024
Q2 | $1M | Hold |
5,856
| – | – | 0.08% | 76 |
|
|
2024
Q1 | $1.07M | Sell |
5,856
-50
| -0.8% | -$8.62K | 0.08% | 73 |
|
|
2023
Q4 | $915K | Sell |
5,906
-316
| -5% | -$46.1K | 0.06% | 73 |
|
|
2023
Q3 | $927K | Hold |
6,222
| – | – | 0.05% | 73 |
|
|
2023
Q2 | $838K | Hold |
6,222
| – | – | 0.05% | 78 |
|
|
2023
Q1 | $992K | Sell |
6,222
-72,802
| -92% | -$11.1M | 0.07% | 69 |
|
|
2022
Q4 | $12.8M | Buy |
79,024
+400
| +0.5% | +$61.3K | 0.39% | 37 |
|
|
2022
Q3 | $10.6M | Hold |
78,624
| – | – | 0.3% | 45 |
|
|
2022
Q2 | $12M | Sell |
78,624
-60,668
| -44% | -$9.27M | 0.37% | 37 |
|
|
2022
Q1 | $22.6M | Buy |
139,292
+7
| +0% | +$1.02K | 0.6% | 24 |
|
|
2021
Q4 | $18.9M | Buy |
139,285
+98,291
| +240% | +$11.6M | 0.36% | 43 |
|
|
2021
Q3 | $4.42M | Sell |
40,994
-3,623
| -8% | -$414K | 0.18% | 48 |
|
|
2021
Q2 | $5.03M | Sell |
44,617
-3,220
| -7% | -$363K | 0.17% | 46 |
|
|
2021
Q1 | $5.18M | Buy |
47,837
+3,928
| +9% | +$420K | 0.16% | 49 |
|
|
2020
Q4 | $4.71M | Buy |
43,909
+2,974
| +7% | +$286K | 0.15% | 53 |
|
|
2020
Q3 | $3.58M | Sell |
40,935
-10,738
| -21% | -$1.01M | 0.12% | 58 |
|
|
2020
Q2 | $5.07M | Buy |
51,673
+5,441
| +12% | +$479K | 0.17% | 43 |
|
|
2020
Q1 | $3.52M | Sell |
46,232
-94,993
| -67% | -$8.09M | 0.14% | 57 |
|
|
2019
Q4 | $12.5M | Sell |
141,225
-1,219
| -0.9% | -$101K | 0.23% | 50 |
|
|
2019
Q3 | $10.8M | Buy |
142,444
+7,109
| +5% | +$487K | 0.19% | 55 |
|
|
2019
Q2 | $9.84M | Buy |
135,335
+21,515
| +19% | +$1.69M | 0.18% | 63 |
|
|
2019
Q1 | $9.17M | Buy |
113,820
+8,189
| +8% | +$670K | 0.25% | 57 |
|
|
2018
Q4 | $9.74M | Buy |
+105,631
| New | +$9.29M | 0.32% | 48 |
|
|
2017
Q3 | – | Sell |
-5,596
| Closed | -$406K | – | 27 |
|
|
2017
Q2 | $406K | Buy |
+5,596
| New | +$376K | 0.02% | 292 |
|
|
2017
Q1 | – | Sell |
-109,302
| Closed | -$6.84M | – | 174 |
|
|
2016
Q4 | $6.84M | Buy |
109,302
+102,802
| +1,582% | +$6.28M | 0.41% | 82 |
|
|
2016
Q3 | $410K | Sell |
6,500
-7,500
| -54% | -$486K | 0.03% | 153 |
|
|
2016
Q2 | $867K | Sell |
14,000
-9,200
| -40% | -$561K | 0.06% | 120 |
|
|
2016
Q1 | $1.32M | Buy |
+23,200
| New | +$1.29M | 0.11% | 126 |
|
Other funds holding ABBV
VCM
VPM
Allstate Corporation's ABBV Position: Q1 2026 in Review
Allstate Corporation increased its AbbVie (ABBV) stake by 36% in Q1 2026, buying an estimated $10.6M and bringing the position to 182,470 shares worth $39.7M. The position accounts for 0.42% of the portfolio, ranked #34.
Allstate Corporation first reported a position in ABBV in Q1 2016 and has held it in 35 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Allstate Corporation held 182,470 shares of AbbVie worth $39.7M as of Q1 2026.
- Allstate Corporation bought 47,985 AbbVie shares in Q1 2026, an estimated $10.6M.
- AbbVie made up 0.42% of Allstate Corporation's portfolio in Q1 2026, its #34 holding.
- Allstate Corporation first reported a position in AbbVie in Q1 2016 and has held it in 35 quarters since.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.